期刊文献+

心房颤动电复律与胺碘酮节律控制的效果——附53例临床观察 被引量:2

Effect of electrical cardioversion combined amiodarone rhythm control in 53 cases with atrial fibrillation
下载PDF
导出
摘要 目的:观察电复律+胺碘酮维持治疗对持续性心房颤动(房颤)节律控制的效果及安全性。方法:回顾分析2007年8月至2010年12月在我院行心脏电复律+胺碘酮维持治疗的53例持续性房颤患者的资料,对复律≥2年的24例患者进行随访,其中维持窦性心律1.5年者16例(复律组),房颤复发者8例(复发组)。结果:53例有50例达到复律早期成功,早期成功率为94.3%,与电复律前比较,电复律后患者的总心室率[(109777±6757)次/min比(81083±5036)次/min]、平均心率[(81±8)次/min比(62±6)次/min]、最快心室率[(145±13)次/min比(123±11)次/min]、最慢心室率[(67±7)次/min比(45±6)次/min]明显减低(P<0.05);与复律组比较,复发组的房颤持续时间[(4.36±1.47)月比(8.7±2.15)月]、左房内径[(35.85±2.07)mm比(43.15±1.95)mm]、年龄[(54.3±11.7)岁比(72.1±8.3)岁]均明显增大(P<0.01~<0.001)。所有病人无明显副作用。结论:电复律联合小剂量胺碘酮维持治疗对大部分持续性房颤患者有效、安全、简便,应该推广。 Objective:To observe effect and safety of electrical cardioversion combined amiodarone rhythm control on patients with persistent atrial fibrillation(AF).Methods: Data of 53 patients with persistent AF by electrical cardioversion and amiodarone maintenance therapy in our hospital from Aug 2007 to Dec 2010 were retrospectively analyzed.A total of 24 patients undergoing cardioversion for over two years were followed up,in which 16 patients maintained sinus rhythm for 1.5 years were regard as conversion group and eight cases recurred AF were enrolled as recurrence group.Results:A total of 50 patients(94.3%) achieved early success among 53 cases.Compared with before electrical cardioversion,there were significant decrease in total ventricular rate [(109777±6757) timesmin vs.(81083±5036) timesmin],mean heart rate [(81±8) timesmin vs.(62±6) timesmin],maximum ventricular rate [(145±13) timesmin vs.(123±11) timesmin]and minimum ventricular rate [(67±7) timesmin vs.(45±6) timesmin]after electrical cardioversion(P0.05 all).Compared with conversion group,there were significant increase in AF duration [(4.36±1.47) months vs.(8.7±2.15) months],left atrial diameter [(35.85±2.07) mm vs.(43.15±1.95) mm]and age [(54.3±11.7) years vs.(72.1±8.3) years]in recurrence group(P0.01~0.001).No obvious side effects occurred in all patients.Conclusion:It is effective,safe and feasible to eliminate persistent atrial fibrillation for most patients by electrical cardioversion combined with low dose amiodarone,must be spread.
出处 《心血管康复医学杂志》 CAS 2012年第4期419-422,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心房颤动 电抗休克 胺碘酮 Atrial fibrillation Electric countershock Amiodarone
  • 相关文献

参考文献12

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2李爱民,黄岚.心房颤动非药物治疗的现状与进展[J].西部医学,2008,20(3):646-648. 被引量:1
  • 3AFFIRM First Antiarrhythmic Drug substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug [J]. J Am Coll Cardiol, 2003, 42 (1): 20-29.
  • 4Daoud EG, Hummel JD, Augostini R, et al. Effect of verapanmil on immediate recurrence of atrial fibrillation [J]. J Cardiovasc Electrophysiol, 2000, 11 (11): 1231-1237.
  • 5赵水平,胡大一.心血管病诊疗指南解读[M].第三版.北京:人民卫生出版社,2008:152-153,164-170,171-175.
  • 6Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an inde pendent risk factor for stroke: the Framingham Study [J]. Stroke, 1991, 22 (8): 983-988.
  • 7周玉杰,马长生,张澍.心房颤动-现代认识与策略[M].第一版.北京:人民卫生出版社,2004:20-23,160-183.
  • 8Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial [J]. Lancet, 2000, 356 (9244): 1789-1794.
  • 9刘英明,胡智,胡媛琴,刘树元,王建斌,费宇行,杨晔.胺碘酮联合加镁极化液转复持续性心房颤动的观察[J].心血管康复医学杂志,2008,17(3):258-261. 被引量:4
  • 10胡清,任惠萍,张百宁.胺碘酮联合电复律转复心房颤动的疗效评价[J].中国医师进修杂志(内科版),2007,30(9):25-27. 被引量:1

二级参考文献24

共引文献1403

同被引文献34

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部